Shopping Cart
- Remove All
- Your shopping cart is currently empty
Cefsulodin (SCE-129) exhibits strong efficacy against Pseudomonas aeruginosa and strains sensitive to penicillin and gentamicin, comparable to gentamicin and dibekacin. However, its effectiveness diminishes against penicillin-resistant Pseudomonas aeruginosa strains, particularly those also resistant to gentamicin. For Pseudomonas maltophilia, SCE-129 shows similar minimum inhibitory concentrations to penicillin, gentamicin, and dibekacin. Pseudomonas cepacia strains usually display moderate resistance to SCE-129 and penicillin, and high resistance to gentamicin and dibekacin.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | Cefsulodin (SCE-129) exhibits strong efficacy against Pseudomonas aeruginosa and strains sensitive to penicillin and gentamicin, comparable to gentamicin and dibekacin. However, its effectiveness diminishes against penicillin-resistant Pseudomonas aeruginosa strains, particularly those also resistant to gentamicin. For Pseudomonas maltophilia, SCE-129 shows similar minimum inhibitory concentrations to penicillin, gentamicin, and dibekacin. Pseudomonas cepacia strains usually display moderate resistance to SCE-129 and penicillin, and high resistance to gentamicin and dibekacin. |
Alias | SCE-129 |
Molecular Weight | 532.55 |
Formula | C22H20N4O8S2 |
Cas No. | 62587-73-9 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.